menu search

Processa pharmaceuticals to present pcs12852 gastroparesis results at the digestive disease week 2023 annual meeting

PCS12852 Shown to be Safe and Efficacious in Phase 2 Proof-of-Concept Trial in gastroparesis Patients P...

April 28, 2023, 12:15 pm

Processa pharmaceuticals to present pcs12852 gastroparesis results at the digestive disease week 2023 annual meeting

HANOVER, MD, April 28, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...

April 28, 2023, 8:15 am

Why are vanda pharma shares plunging today?

Vanda Pharmaceuticals Inc  VNDA shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of ...

February 4, 2022, 8:34 am

Why are vanda pharma shares plunging today?

Vanda Pharmaceuticals Inc  VNDA shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of ...

February 4, 2022, 8:34 am

Why are vanda pharma shares plunging today?

Vanda Pharmaceuticals Inc  VNDA shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of ...

February 4, 2022, 8:34 am


Search within

Pages Search Results: